CASI News and Press, CASI Pharmaceuticals Inc. From 08/09/19

CASI Pharmaceuticals (NASDAQ: CASI ): Q2 GAAP EPS of -$0.16 misses by $0.07 . More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ROCKVILLE, Md. , Aug. 9, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing  therapeutics and pharmaceutical products in China , U.S., and throughout the world, today reported financial resu...

Deals and Financings Beijing's BeiGene ([[BGNE]]; HK: 06160) will receive a $150 million termination payment from Celgene (CELG) because Celgene will end its $1.4 billion partnership for ex-China rights to BeiGene's PD-1 candidate. The original deal included a provision that BeiGene's ti...

CASI Pharmaceuticals (NASDAQ: CASI ) has signed a license agreement for exclusive worldwide rights to an anti-CD19 T-cell therapy product (CNCT19) from Juventas Cell Therapy Ltd., a China-based domestic company. More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, Stocks on th...

ROCKVILLE, Md. , June 17, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company that is focusing on developing and accelerating the launch of innovative therapeutics and pharmaceutical products in China , the U.S., and throughout the world,...

Gainers:  Coda Octopus Group (NASDAQ: CODA ) +40% . Mmtec (NASDAQ: MTC ) +30% . Red Robin Gourmet Burgers (NASDAQ: RRGB ) +29% . DryShips (NASDAQ: DRYS ) +24% . Cemtrex (NASDAQ: CETX ) +21% . Ruhnn Holding Limited (NASDAQ: RUHN ) +21% . RH (NYSE: RH ) +20% . Aeterna Zentaris (N...

Introduction Every year the Russell Indexes are rebalanced to bring in new stocks and remove underperforming stocks. The FTSE Russell calls this event the annual reconstitution process, and it begins with evaluations in May and moves to the selection process on June 7th with the newly recons...

ROCKVILLE, Md. , June 3, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company with a platform to develop and accelerate the launch of innovative therapeutics and pharmaceutical products in China , the U.S., and throughout the world, announces i...

ROCKVILLE, Md. , May 15, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. pharmaceutical company with a platform to develop and accelerate the launch of innovative therapeutics and pharmaceutical products in China , the U.S., and throughout the world, today rep...

Deals and Financings Hutchison China MediTech (Chi-Med) [AIM:HCM] (HCM) filed to IPO on the Hong Kong Exchange, following listings in London and on NASDAQ, where it has a market capitalization of over $4 billion (see story ). In September 2018, Chi-Med was approved to launch fruquintinib in...